Image credit: Nushin Rashidian

As the FDA Turns to Congress for CBD Regs, Here’s Who’s Been Lobbying on CBD

Now that Congress will play a bigger role in the future of the CBD industry, will more companies try to sway the outcome?

CBD
Newsletter, Regulation

Who’s Calling for a Hearing on Rescheduling?

An excerpt from the Cannabis Wire Daily newsletter.

Newsletter

From Congress to Iowa and Colorado, New Battles Brew Over Intoxicating Hemp

An excerpt from the Cannabis Wire Daily newsletter.